Statin use after acute myocardial infarction: a nationwide study in Denmark

被引:34
|
作者
Rasmussen, JN
Gislason, GH
Abildstrom, SZ
Rasmussen, S
Gustafsson, I
Buch, P
Friberg, J
Kober, L
Torp-Pedersen, C
Madsen, M
Stender, S
机构
[1] Natl Inst Publ Hlth, DK-1399 Copenhagen, Denmark
[2] Ghent Univ Hosp, Dept Clin Biochem, Hellerup, Denmark
[3] Bispebjerg Hosp, Dept Cardiovasc Med, Copenhagen, Denmark
[4] Natl Univ Hosp, Rigshosp, Ctr Heart, Dept Cardiol, Copenhagen, Denmark
关键词
acute myocardial infarction; secondary prevention; statins; epidemiology; drug prescription;
D O I
10.1111/j.1365-2125.2005.02408.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims To study outpatient statin use after first acute myocardial infarction (AMI) in Denmark between 1995 and 2002 and to determine the predictors of statin use. Methods This is a nationwide population-based study using administrative registries. Patients with first AMI between 1995 and 2002 older than 30 years of age and alive 6 months after discharge (n = 45 219) were identified through the National Patient Registry. The statins purchased by these patients within 6 months after discharge were determined using the Registry of Medicinal Product Statistics, a nationwide prescription database. Results Statin use following AMI increased from 13% in 1995 to 61% in 2002. In 2002, 81% of patients aged 30-64 years used statins. Older patients used fewer statins, but use increased more among patients aged 75-84 years: from 1.3% to 43%. Use in elderly patients did not differ according to gender in 2000-02, but young men used more than younger women. In 2000-02, patients with diabetes (odds ratio (OR): 0.84; 95% confidence interval (CI): 0.74-0.95) and with heart failure (OR: 0.70; 95% CI: 0.64-0.76) were undertreated; this trend was present throughout the period. Conclusions In this nationwide study, younger patients after AMI had high statin use in 2002, but high-risk patients such as those with diabetes and heart failure were still being undertreated.
引用
收藏
页码:150 / 158
页数:9
相关论文
共 50 条
  • [41] Dental prophylaxis decreases the risk of acute myocardial infarction: a nationwide population-based study in Taiwan
    Lee, Ya-Ling
    Hu, Hsiao-Yun
    Chou, Pesus
    Chu, Dachen
    CLINICAL INTERVENTIONS IN AGING, 2015, 10 : 175 - 182
  • [42] GFR and Cardiovascular Outcomes After Acute Myocardial Infarction: Results From the Korea Acute Myocardial Infarction Registry
    Bae, Eun Hui
    Lim, Sang Yup
    Cho, Kyung Hoon
    Choi, Joon Seok
    Kim, Chang Seong
    Park, Jeong Woo
    Ma, Seong Kwon
    Jeong, Myung Ho
    Kim, Soo Wan
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (06) : 795 - 802
  • [43] Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial
    Leone, Antonio Maria
    Rutella, Sergio
    Giannico, Maria Benedetta
    Perfetti, Matteo
    Zaccone, Vincenzo
    Brugaletta, Salvatore
    Garramone, Barbara
    Niccoli, Giampaolo
    Porto, Italo
    Liuzzo, Giovanna
    Biasucci, Luigi Marzio
    Bellesi, Silvia
    Galiuto, Leonarda
    Leone, Giuseppe
    Rebuzzi, Antonio Giuseppe
    Crea, Filippo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 130 (03) : 457 - 462
  • [44] Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014
    Rosenson, Robert S.
    Farkouh, Michael E.
    Mefford, Matthew
    Bittner, Vera
    Brown, Todd M.
    Taylor, Ben
    Monda, Keri L.
    Zhao, Hong
    Dai, Yuling
    Muntner, Paul
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (22) : 2696 - 2706
  • [45] Assessment of Lipophilic vs. Hydrophilic Statin Therapy in Acute Myocardial Infarction - ALPS-AMI Study -
    Izawa, Atsushi
    Kashima, Yuichiro
    Miura, Takashi
    Ebisawa, Soichiro
    Kitabayashi, Hiroshi
    Yamamoto, Hiroaki
    Sakurai, Shunpei
    Kagoshima, Mitsuru
    Tomita, Takeshi
    Miyashita, Yusuke
    Koyama, Jun
    Ikeda, Uichi
    CIRCULATION JOURNAL, 2015, 79 (01) : 161 - 168
  • [46] Myocardial revascularisation after acute myocardial infarction
    Bana, A
    Yadava, OP
    Ghadiok, R
    Selot, N
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1999, 69 (02) : 209 - 216
  • [47] Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study
    Charlot, Mette
    Nielsen, Lars Hougaard
    Lindhardsen, Jesper
    Ahlehoff, Ole
    Olsen, Anne-Marie S.
    Hansen, Morten Lock
    Hansen, Peter Riis
    Madsen, Jan Kyst
    Kober, Lars
    Gislason, Gunnar H.
    Torp-Pedersen, Christian
    EUROPEAN HEART JOURNAL, 2012, 33 (20) : 2527 - 2534
  • [49] Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002
    Gislason, GH
    Abildstrom, SZ
    Rasmussen, JN
    Rasmussen, S
    Buch, P
    Gustafsson, I
    Friberg, J
    Gadsboll, N
    Kober, L
    Stender, S
    Madsen, M
    Torp-Pedersen, C
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2005, 39 (1-2) : 42 - 49
  • [50] Patterns of Statin Initiation, Intensification, and Maximization Among Patients Hospitalized With an Acute Myocardial Infarction
    Arnold, Suzanne V.
    Kosiborod, Mikhail
    Tang, Fengming
    Zhao, Zhenxiang
    Maddox, Thomas M.
    McCollam, Patrick L.
    Birt, Julie
    Spertus, John A.
    CIRCULATION, 2014, 129 (12) : 1303 - 1309